The VMAT2 inhibitor valbenazine for use in a method of treating a neurological or psychiatric disorder in patients with severe renal impairment
MDE20260630A1Pending Publication Date: 2026-09-30NEUROCRINE BIOSCIENCES INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MDE20260630T
- Authority / Receiving Office
- MD · MD
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-08-23
- Filing Date
- 2020-08-21
- Publication Date
- 2026-09-30
Need to check novelty before this filing date? Find Prior Art
No text content released.